Season 1 Episode 6: Advancing Women's Health: Bridging Gaps in Innovation and Action
The sixth episode of Biotech Pulse features an in-depth look at the challenges and opportunities in women’s health innovation. The episode is introduced by our Senior Associate Vanessa Carle, PhD and focuses on the inaugural Forbion EU Impact Roundtable held on October 16, 2024.
Get ready to hear from our distinguished panel of experts: Geert-Jan Mulder, Managing Partner at Forbion, Trine Bartholdy, Chief Innovation Officer at the BioInnovation Institute. Mary Kerr, CEO of NeRRe Therapeutics, Kelle Moley, Global VP of Clinical and Translational R&D in Reproductive Medicine and Maternal Health at Ferring Pharmaceuticals and Diana Torgersen, Head of Innovation Ecosystem Integration at Organon.
The panel unpacked the insights shared by leading experts from academia, biotech, pharma, and venture capital and explored critical barriers hindering progress in women’s health, including a fragmented research ecosystem, limited commercial investment incentives, and regulatory challenges.
Tune in for a thought-provoking exploration of how to address inequities and foster advancements in this vital but underserved area of women's health.
About The Biotech Pulse - a Forbion podcast
Forbion is a leading life sciences venture capital firm founded in the Netherlands, helping companies bridge research and development through our team's expertise in drug development and company building. For over 15 years, we have invested in over 100 companies backing exciting therapies that we believe have the potential to impact the future of medicine. The Biotech Pulse is a forum where we speak about all things biotech with diverse stakeholders in the life sciences industry.